Health carriers required to offer reference-based pricing health plans, open-ended promise-to-pay contracts prohibited, provider number framework established, and rulemaking authorized.
HF4992 would significantly restructure how certain health care prices are set, disclosed, and collected in Minnesota. It requires health carriers in the individual, small group, and large group markets to offer a reference-based pricing health plan, under which reimbursement is tied to a percentage of Medical Assistance fee-for-service rates rather than negotiated provider prices. The bill also creates a new statewide “provider number” system, directing the commissioner of health to calculate and publicly post each provider’s number, and authorizes consumer-facing private health information exchanges to aggregate and display pricing, quality, and review data.
The bill further prohibits health care providers from using open-ended promise-to-pay contracts, making such agreements void and unenforceable for services rendered on or after July 1, 2026, unless they disclose specific estimated patient responsibility and provider-number information. It also bars hospitals and other health care facilities from billing patients or payers for the treatment costs of hospital-associated infections acquired in the facility, shifting financial responsibility for those costs to the facility where the infection occurred. In addition, the bill authorizes rulemaking by the commissioner of health to implement the provider-number and exchange framework and to promote price transparency, competition, and reduced surprise billing.
HF4992 would amend Minnesota Statutes chapters 62J and 62K and create new law governing health care pricing, billing practices, and insurance product offerings. It would impose new obligations on health carriers to offer reference-based pricing plans, require providers to accept specified reimbursement amounts if they participate, prohibit certain patient financial agreements, and establish public reporting and consumer comparison tools. It would also create a new liability rule for hospital-associated infection treatment costs, effectively shifting those costs away from patients and payers and onto the facility where the infection was acquired.
Based on the bill text and available context, the bill appears to be framed as a consumer-protection and transparency measure aimed at lowering costs and reducing surprise billing. The stated goals emphasize competition, clearer pricing, and eliminating hidden charges, suggesting generally favorable intent toward patients and purchasers of health care. No committee transcript or vote record is available here, so there is no documented public debate or recorded sentiment beyond the bill’s own policy framing.
The most likely points of contention are the bill’s impact on provider revenue, contracting flexibility, and administrative burden. Hospitals and providers may object to the prohibition on billing for hospital-associated infection treatment costs, the ban on open-ended promise-to-pay contracts, and the requirement to publish provider numbers and participate in standardized pricing disclosures. Health carriers and providers may also dispute the reference-based pricing mandate, the use of Medical Assistance rates as the benchmark, and the extent to which the bill could affect network design, reimbursement negotiations, and compliance costs. The bill’s requirement that providers accept set rates as payment in full if they opt in may also be controversial among provider groups.